92 results on '"Yang HAN"'
Search Results
2. TCT-372 Hemodynamic Performance of the Intra-Annular and the Supra-Annular Aortic Valves for Transcatheter Aortic Valve Replacement
3. TCT-380 The Impact of Obesity on Antiplatelet Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Substudy of the HOST-EXAM Trial
4. TCT-22 Clopidogrel Versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Subgroup Analysis of the HOST-EXAM Trial
5. TCT-15 Dual Antiplatelet Therapy–Based Deescalation in Acute Coronary Syndrome: An Individual Patient Data Meta-analysis
6. SHORT-TERM DUAL ANTIPLATELET THERAPY REDUCES BLEEDING RISK WITHOUT INCREASING ISCHEMIC RISK IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION WITH THIRD-GENERATION DRUG-ELUTING STENTS: A POST HOC ANALYSIS OF THE HOST-IDEA TRIAL
7. Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial
8. PRASUGREL DE-ESCALATION THERAPY IN ACUTE CORONARY SYNDROME WITH DIABETES MELLITUS: HOST-REDUCE-POLYTECH-ACS DM SUBGROUP ANALYSIS
9. RISK OF ISCHEMIC AND BLEEDING ADVERSE EVENTS IN HIGH BLEEDING RISK PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: 10 YEAR OUTCOME OF A NATIONWIDE COHORT STUDY
10. DURABLE POLYMER AND BIODEGRADABLE POLYMER DRUG-ELUTING STENTS AFTER COMPLEX CORONARY INTERVENTION IN ACUTE CORONARY SYNDROME: A POST HOC ANALYSIS FROM THE HOST-REDUCE-POLYTECH-ACS TRIAL
11. TCT-8 Prasugrel De-Escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial
12. TCT-6 Impact of Diabetes Mellitus on the Effectiveness of Aspirin Versus Clopidogrel as a Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Trial
13. TCTAP A-051 Angiographic Complete Revascularization Versus Incomplete Revascularization in Patients with Diabetes Mellitus
14. TCTAP A-002 Limitation of Angiographic Parameters in Predicting Residual Ischemia After Drug-eluting Stent Implantation
15. TCT-260 Procedural Optimization Improved the Clinical Outcome of Drug-Coated Balloon for DES-ISR: Proposal of the “DCB 4 Factors”
16. TCT-195 Anatomical Attributes of Myocardial Territory of Diagonal Branches Assessed by Coronary Computed Tomography Angiography
17. TCT-632 Complete Revascularization of Multivessel Coronary Artery Disease Does Not Improve Clinical Outcome in ST-Segment Elevation Myocardial Infarction Patients With Diabetes Mellitus
18. TCT-836 The Ratio Serum Creatinine/Serum Cystatin C as a Predictor of Ischemic Risk in Elderly Patients With Coronary Artery Disease
19. TCT-412 Side Branch Intervention for Non-Left Main True Bifurcation Lesions: Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort
20. TCT-679 The impact of complete revascularization in STEMI patients with left ventricular dysfunction
21. TCT-727 Relevance of type and dose of beta-blockers in prognosis among patients with ischemic heart disease: Data from GRAND-DES Registry
22. TCT-580 Relationship between adverse plaque characteristics and wall shear stress assessed by computational fluid dynamics
23. TCTAP A-003 Prognosis and Predictors of Lesion Failure After Left Main Bifurcation Intervention: Pooled Analysis of Korean Multicenter Drug-eluting Stent Cohort
24. TCT-29 Mechanism of Low Fractional Flow Reserve in Lesions without angiographic significant stenosis: Role of hidden Plaque Burden
25. TCT-754 One-year clinical outcome of patients treated with Resolute Onyx versus Resolute Integrity: A Comparison of the HOST-ONYX and HOST-RESOLINTE Registries
26. TCT-413 Clinical Relevance of Adverse Plaque and Hemodynamic Characteristics in Non-obstructive Lesions in the Prediction of Risk for Acute Coronary Syndrome
27. TCT-415 The influence of sex on fractional flow reserve is different by lesion location
28. TCT-753 Long-Term Comparison of Platinum Chromium Everolimus-Eluting and Cobalt Chromium Zotarolimus-Eluting Stents: Three-Year Outcome of the HOST-ASSURE Randomized Trial
29. TCT-218 The ‘SYNTAX Score derivatives’ to predict clinical outcomes after percutaneous coronary intervention with Everolimus-eluting stents for Left main/three vessel disease patients
30. TCT-459 Real-world experience of biolimus A9- and everolimus-eluting stents in all-comer Korean registries: Patient-oriented and stent-related 3-year outcomes from the multicenter prospective Biolimus-Korea-3000 registry and Excellent-Prime registry
31. BASELINE SYNTAX SCORE PREDICTS CLINICAL OUTCOME AFTER COMPLETE REVASCULARIZATION IN PATIENTS WITH MULTIVESSEL DISEASE
32. THE CLINICAL SYNTAX SCORE IS SUPERIOR TO THE SYNTAX SCORE IN HIGH-RISK PATIENTS
33. REAL-WORLD EXPERIENCE OF BIOLIMUS A9-ELUTING STENTS AND COMPARISON WITH EVEROLIMUS-ELUTING XIENCE PRIME STENTS IN ALL-COMER REGISTRIES: PRELIMINARY REPORT FOR PATIENT-ORIENTED AND STENT-RELATED 2-YEAR OUTCOMES FROM THE MULTICENTER PROSPECTIVE BIOLIMUS-KOREA-3000 REGISTRY AND EXCELLENT-PRIME REGISTRY
34. TCTAP A-135 Physiological Characteristics of Discordance Between Fractional Flow Reserve and Instantaneous Wave-Free Ratio
35. HOW TO OPTIMIZE DRUG-ELUTING BALLOON ANGIOPLASTY FOR IN-STENT RESTENOSIS: HOST-ISR DEB REGISTRY
36. WHICH IS BETTER, ABSOLUTE FLOW OR CORONARY FLOW RESERVE FOR THE DETECTION OF SIGNIFICANT CORONARY ARTERY STENOSIS? VALIDATION USING FRACTIONAL FLOW RESERVE AND POSITRON EMISSION TOMOGRAPHY
37. ADDITIVE VALUE OF QUANTITATIVE PERFUSION PARAMETERS OF CARDIAC POSITRON EMISSION TOMOGRAPHY IN THE DETECTION OF FUNCTIONALLY SIGNIFICANT CORONARY STENOSIS
38. TCT-581 Long-term Patient-related and Stent-related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents versus Zotarolimus-Eluting Resolute Stents in Real-World Practice: Three Year Results From the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries
39. TCT-270 Comparison Among Drug-eluting Balloon, Drug-eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials
40. TCT-257 Efficacy of Short-Term High-Dose Statin Pretreatment in Prevention of Contrast-Induced Nephropathy: Updated Study-Level Meta-Analysis of 13 Randomized Controlled Trials
41. TCT- 65 The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention with or without Cardiogenic Shock: Bayesian Approach Network Meta-Analysis of 13 Randomized Controlled Trials
42. PRIMING WITH ERYTHROPOIETIN IMPROVES VASCULOGENIC POTENTIAL OF HUMAN PERIPHERAL BLOOD STEM CELLS THAT ARE MOBILIZED WITH GRANULOCYTE COLONY-STIMULATING FACTOR
43. VARIABILITY OF FRACTIONAL FLOW RESERVE ACCORDING TO THE VARIOUS METHODS TO INDUCE HYPEREMIA
44. SAFETY AND EFFICACY OF NOVEL HYPEREMIC AGENT, NICORANDIL, FOR FRACTIONAL FLOW RESERVE MEASUREMENT
45. ACTIVATED PLATELET SUPERNATANT CAN AUGMENT THE ANGIOGENIC POTENTIAL OF PERIPHERAL BLOOD STEM CELLS IN STEM CELL-BASED THERAPY
46. SILDENAFIL INHIBITS PLATELET AGGREGATION AND REDUCES NEOINTIMAL HYPERPLASIA AFTER VASCULAR INJURY
47. THE IMPACT OF PATIENT AND LESION COMPLEXITY IN CLINICAL OUTCOMES OF SECOND–GENERATION EVEROLIMUS–ELUTING STENTS VERSUS ZOTAROLIMUS–ELUTING RESOLUTE STENTS IN REAL–WORLD PRACTICE: PATIENT–RELATED AND STENT–RELATED OUTCOMES FROM THE MULTICENTER PROSPECTIVE EXCELLENT AND RESOLUTE–KOREA REGISTRIES
48. Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice
49. TCT-732 Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention
50. SILDENAFIL INHIBITS VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET AGGREGATION VIA ACTIVATION OF PROTEIN KINASE G (PKG), RESULTING IN REDUCING NEOINTIMAL HYPERPLASIA AFTER ANGIOPLASTY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.